"Individuals with O blood type are between 9-18% percent less likely than individuals with other blood types to have tested positive for COVID-19, according to the data", a company statement said at the time.
The researchers maintained that the cause of such a side effect is still unknown. It is aimed at understanding the clinical effect of molecular point-of-care testing in suspected COVID-19 patients admitted at UHS.
Experts say there is still further research needed to verify this information.
Frederic Altare, director of Immunology at the Inserm Research Centre of Oncology and Immunology Nantes-Angers, said there was now little evidence that COVID-19 reinfection was going to be a "major issue" given the low case figures.
A 45-year-old man being treated for severe COVID-19 in the United Kingdom suddenly lost the hearing in one ear, according to doctors writing in journal BMJ Case Reports. However, the condition sometimes follows a viral infection, such as flu or herpes.
"As early career researchers this study provided us with a valuable learning opportunity about how to deliver academic impact within the evolving COVID-19 pandemic".
Pau Gasol reacts to the Lakers winning the 2020 National Basketball Association championship
Kobe won five National Basketball Association titles during his 20 years as a Laker, and the team dedicated this season to him. Kobe and Gianna , 13, were killed in January along with seven others when their helicopter crashed during foggy weather.
The scientists believe that he had not lost his hearing or had ear problems before, and had only asthma as co-morbidity. Steroid tablets and injections helped him to partially recover, the report reads.
That's because mucus membranes "tend to get very stuffy", so fluid can build up behind the eardrum, Michaelides said.
Like many researchers, they found antibodies to the coronavirus spiked immediately following infection and then crashed. Other isolated cases of reinfection have been reported around the world, including in Asia and Europe.
It's known that some medications such as remdesivir, chloroquine and hydroxychloroquine - drugs now being used to treat coronavirus patients - can cause ear damage.
The second research is based on almost 95 people from Vancouver, Canada who had tested positive for the virus. "If SARS-CoV-2 is anything like the first one, we expect antibodies to last at least two years, and it would be unlikely for anything much shorter", he said.
As per the Netherlands' National Institute for Public Health and the Environment, an 89-year-old Dutch woman succumbed to COVID-19 after contracting it for the second time. They align with the findings of a third study published in June in the New England Journal of Medicine that looked at genetic data to determine that those with type A blood were at a higher COVID-19 risk and those with type O. She's an alumna of Boston University and has reported for the Wall Street Journal, Science, and The Boston Globe.